Does MRI Screening Help Diagnose Hip Osteonecrosis Early in Children With Leukemia Receiving Cortisone Treatment?

According to a study published in the American Journal of Clinical Oncology, early hip MRI screening in children older than 10 with leukemia receiving cortisone treatment can detect extensive hip osteonecrosis early and allow timely intervention.
Bones consist of living cells and need blood flow to remain viable. If blood flow to bone is interrupted for any reason, the bone loses its viability and a condition called osteonecrosis (bone death) develops. Usually asymptomatic early on, osteonecrosis causes joint pain and restricted movement as it progresses. However, by the time these symptoms appear, it is often advanced and causes hip bone fractures, consequently requiring joint replacement surgery.
The most common cause of osteonecrosis, which frequently affects the hip, is prolonged high-dose cortisone use. Cortisone is a very valuable, beneficial drug. The most important medicine for many diseases and the only medicine for some, it also has an indispensable role in cancer treatment. It is very useful both for directly treating many cancers and for treating chemotherapy side effects. Acute lymphoblastic leukemia (ALL), the most common blood cancer in children, is among the cancers in which cortisone is used most intensively, and cortisone-related osteonecrosis is common in these patients. A recently published study therefore investigated whether hip MRI screening would help diagnose osteonecrosis early in children with ALL receiving cortisone.
The study enrolled children with ALL receiving cortisone who had no hip complaints: 462 children underwent hip MRI screening at 6 months after diagnosis, 9 months, and the end of chemotherapy, for a total of 3 scans, and were assessed for hip osteonecrosis. Among children older than 10, a total of 40 extensive hip osteonecroses were detected; 19 required total hip replacement, and none showed a tendency to heal. In contrast, in children aged 10 and younger, only 8 extensive hip osteonecroses were detected; none required total hip replacement, and 4 showed a tendency to heal.
In conclusion, patients aged 10 and younger receiving cortisone do not need MRI screening for early diagnosis of extensive hip osteonecrosis because their risk is low and, even if osteonecrosis develops, it usually tends to heal. However, in children older than 10, early hip MRI screening can detect extensive osteonecrosis early and allow timely intervention. Early hip MRI screening in children older than 10 receiving cortisone would therefore be a highly beneficial approach. More time and studies are nevertheless needed before this can become routine screening.
Sources
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.